Stephane Epelbaum
Stephane Epelbaum
Praticien Hospitalier, Pitié Salpêtrière University Hospital
Email verificata su aphp.fr
Titolo
Citata da
Citata da
Anno
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ...
The Lancet Neurology 13 (6), 614-629, 2014
18312014
Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria
B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ...
Alzheimer's & Dementia 12 (3), 292-323, 2016
5602016
Pure alexia as a disconnection syndrome: new diffusion imaging evidence for an old concept
S Epelbaum, P Pinel, R Gaillard, C Delmaire, M Perrin, S Dupont, ...
Cortex 44 (8), 962-974, 2008
2462008
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020
H Hampel, S Lista, SJ Teipel, F Garaci, R Nistico, K Blennow, ...
Biochemical pharmacology 88 (4), 426-449, 2014
992014
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
HM Lanoiselée, G Nicolas, D Wallon, A Rovelet-Lecrux, M Lacour, ...
PLoS medicine 14 (3), e1002270, 2017
932017
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World …
P Lewczuk, P Riederer, SE O’Bryant, MM Verbeek, B Dubois, PJ Visser, ...
The world journal of biological psychiatry 19 (4), 244-328, 2018
852018
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
B Dubois, S Epelbaum, F Nyasse, H Bakardjian, G Gagliardi, ...
The Lancet Neurology 17 (4), 335-346, 2018
672018
Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: a feasibility study
C Boutet, M Chupin, S Lehéricy, L Marrakchi-Kacem, S Epelbaum, ...
NeuroImage: Clinical 5, 341-348, 2014
652014
Preclinical Alzheimer's disease: a systematic review of the cohorts underlying the concept
S Epelbaum, R Genthon, E Cavedo, MO Habert, F Lamari, G Gagliardi, ...
Alzheimer's & Dementia 13 (4), 454-467, 2017
432017
Symptomatic and proven de novo amyloid polyneuropathy in familial amyloid polyneuropathy domino liver recipients
D Adams, C Lacroix, T Antonini, P Lozeron, C Denier, AM Kreib, ...
Amyloid 18 (sup1), 174-177, 2011
402011
Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total‐tau …
H Hampel, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ...
Alzheimer's & Dementia 14 (4), 492-501, 2018
382018
Verbal memory impairment in subcortical ischemic vascular disease: a descriptive analysis in CADASIL
S Epelbaum, S Benisty, S Reyes, M O'Sullivan, E Jouvent, M Düring, ...
Neurobiology of aging 32 (12), 2172-2182, 2011
342011
17q21. 31 duplication causes prominent tau-related dementia with increased MAPT expression
K Le Guennec, O Quenez, G Nicolas, D Wallon, S Rousseau, AC Richard, ...
Molecular psychiatry 22 (8), 1119-1125, 2017
332017
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
S Lista, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ...
Neurochemistry international 108, 355-360, 2017
312017
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ...
Alzheimer's & Dementia 15 (3), 465-476, 2019
302019
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease
F Baldacci, N Toschi, S Lista, H Zetterberg, K Blennow, I Kilimann, ...
Alzheimer's & Dementia 13 (9), 993-1003, 2017
282017
Alzheimer disease: from biomarkers to diagnosis
B Dubois, S Epelbaum, A Santos, F Di Stefano, A Julian, A Michon, ...
Revue neurologique 169 (10), 744-751, 2013
272013
Added value of 18F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study
M Ceccaldi, T Jonveaux, A Verger, P Krolak‐Salmon, C Houzard, ...
Alzheimer's & Dementia 14 (3), 293-305, 2018
252018
Acute amnestic encephalopathy in amyloid-β oligomer–injected mice is due to their widespread diffusion in vivo
S Epelbaum, I Youssef, PN Lacor, P Chaurand, E Duplus, B Brugg, ...
Neurobiology of aging 36 (6), 2043-2052, 2015
232015
Free and Cued Selective Reminding Test–accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large-scale biomarker-characterized monocenter …
M Teichmann, S Epelbaum, D Samri, ML Nogueira, A Michon, H Hampel, ...
Alzheimer's & Dementia 13 (8), 913-923, 2017
222017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20